Minerva Neurosciences, Inc. (NERV) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the…
Source: Yahoo Finance
Sector & Industry
Minerva Neurosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Minerva Neurosciences, Inc. at a Glance
| Company | Minerva Neurosciences, Inc. |
| Ticker | NERV |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $4.43 |
| Market cap | $211.52M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$36.12 |
| 52-week high | $12.46 |
| 52-week low | $1.93 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | -0.10 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 254,649 |
| Shares outstanding | 47.75M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 7 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Minerva Neurosciences, Inc.'s current P/E ratio?
- Minerva Neurosciences, Inc. (NERV) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Minerva Neurosciences, Inc.'s market capitalisation?
- Minerva Neurosciences, Inc.'s market cap is $211.52M based on our latest snapshot. See how it ranks by market cap →
- What is NERV's 52-week range?
- Over the past 52 weeks, NERV has traded between $1.93 and $12.46. What does the 52-week range mean? →
- How volatile is Minerva Neurosciences, Inc. compared to the market?
- Minerva Neurosciences, Inc. has a beta of -0.10, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Minerva Neurosciences, Inc. pay a dividend?
- Minerva Neurosciences, Inc. does not currently pay a dividend according to our latest data.
- What exchange is NERV listed on?
- NERV is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Minerva Neurosciences, Inc. in?
- Minerva Neurosciences, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →